Involvement of BH3-only proteins in hematologic malignanciesKURODA, Junya; TANIWAKI, Masafumi.Critical reviews in oncology/hematology. 2009, Vol 71, Num 2, pp 89-101, issn 1040-8428, 13 p.Article

Renal vein lymphoma embolism in non-Hodgkin lymphomaYAMAMOTO, Mio; KURODA, Junya; KOBAYASHI, Tsutomu et al.International journal of hematology. 2008, Vol 88, Num 5, pp 613-615, issn 0925-5710, 3 p.Article

Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemiaMIZUTANI, Shinsuke; KURODA, Junya; SHIMIZU, Daisuke et al.International journal of hematology. 2010, Vol 91, Num 3, pp 516-521, issn 0925-5710, 6 p.Article

Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell linesKIMURA, Shinya; KURODA, Junya; SEGAWA, Hidekazu et al.International journal of hematology. 2004, Vol 79, Num 1, pp 37-43, issn 0925-5710, 7 p.Article

Aplastic anemia evolving into overt myelodysplastic syndrome/acute myeloid leukemia with t(3;5)(p25;q31)KAWATA, Eri; KURODA, Junya; KIMURA, Shinya et al.Cancer genetics and cytogenetics. 2002, Vol 137, Num 2, pp 91-94, issn 0165-4608Article

Unusual myelodysplastic syndrome with the initial presentation mimicking idiopathic thrombocytopenic purpuraKURODA, Junya; KIMURA, Shinya; KOBAYASHI, Yutaka et al.Acta haematologica. 2002, Vol 108, Num 3, pp 139-143, issn 0001-5792Article

Selective preparation of poly(p-oxybenzoyl) by using fractional polycondensationKIMURA, Kunio; KOHAMA, Shin-Ichiro; KURODA, Junya et al.Journal of polymer science. Part A. Polymer chemistry. 2006, Vol 44, Num 8, pp 2732-2743, issn 0887-624X, 12 p.Article

Agranular CD4+CD56+ blastic natural killer leukemia/lymphomaKIMURA, Shinya; KAKAZU, Naoki; KURODA, Junya et al.Annals of hematology (Print). 2001, Vol 80, Num 4, pp 228-231, issn 0939-5555Article

Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosisNAGOSHI, Hisao; KURODA, Junya; MATSUMOTO, Yosuke et al.International journal of hematology. 2013, Vol 98, Num 3, pp 366-374, issn 0925-5710, 9 p.Article

ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanismsKURODA, Junya; KIMURA, Shinya; MATSUMOTO, Yosuke et al.British journal of haematology. 2008, Vol 140, Num 2, pp 181-190, issn 0007-1048, 10 p.Article

Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell linesMATSUMOTO, Seiji; KIMURA, Shinya; SEGAWA, Hidekazu et al.Lung cancer. 2005, Vol 47, Num 1, pp 31-39, issn 0169-5002, 9 p.Article

p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acidKURODA, Junya; KIMURA, Shinya; MAEKAWA, Taira et al.Cancer science. 2004, Vol 95, Num 2, pp 186-192, issn 1347-9032, 7 p.Article

Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphomaKIMURA, Shinya; HORIE, Akeyo; YOSHIKAWA, Toshikazu et al.Blood. 2003, Vol 101, Num 10, pp 4219-4221, issn 0006-4971, 3 p.Article

Primary cardiac lymphoma with variant burkitt-type translocation, t(8;22)(q24;q11)KURODA, Junya; KIMURA, Shinya; AKAOGI, Teruaki et al.American journal of hematology. 2000, Vol 65, Num 4, pp 327-328, issn 0361-8609Article

Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke — Research for Biomarkers in Ischemic Stroke (REBIOS)KUWASHIRO, Takahiro; AGO, Tetsuro; ISOMURA, Tetsu et al.Metabolism, clinical and experimental. 2014, Vol 63, Num 9, pp 1093-1103, issn 0026-0495, 11 p.Article

Extracellular Acidification Activates cAMP Responsive Element Binding Protein via Na⁺/H⁺ Exchanger Isoform 1―Mediated Ca²⁺ Oscillation in Central Nervous System PericytesNAKAMURA, Kuniyuki; KAMOUCHI, Masahiro; ARIMURA, Koichi et al.Arteriosclerosis, thrombosis, and vascular biology. 2012, Vol 32, Num 11, pp 2670-2677, issn 1079-5642, 8 p.Article

Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myelomaKIYOTA, Miki; KOBAYASHI, Tsutomu; CHINEN, Yoshiaki et al.International journal of hematology. 2012, Vol 95, Num 5, pp 516-526, issn 0925-5710, 11 p.Article

Hydrogen peroxide-induced Ca²⁺ responses in CNS pericytesKAMOUCHI, Masahiro; KITAZONO, Takanari; AGO, Tetsuro et al.Neuroscience letters. 2007, Vol 416, Num 1, pp 12-16, issn 0304-3940, 5 p.Article

A third-generation bisphosphonate, Minodronic acid (YM529), augments the interferon α/β-mediated inhibition of renal cell cancer cell growth both in vitro and in vivoYUASA, Takeshi; NOGAWA, Masaki; KIMURA, Shinya et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 853-859, issn 1078-0432, 7 p., 1Article

Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agentsKURODA, Junya; SHIMURA, Yuji; ISHII, Kazuyoshi et al.International journal of hematology. 2014, Vol 99, Num 4, pp 441-449, issn 0925-5710, 9 p.Article

Intensity of Anticoagulation and Clinical Outcomes in Acute Cardioembolic Stroke: The Fukuoka Stroke RegistryNAKAMURA, Asako; AGO, Tetsuro; KAMOUCHI, Masahiro et al.Stroke (1970). 2013, Vol 44, Num 11, pp 3239-3242, issn 0039-2499, 4 p.Article

β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse ModelASHIHARA, Eishi; KAWATA, Eri; KAMITSUJI, Yuri et al.Clinical cancer research (Print). 2009, Vol 15, Num 8, pp 2731-2738, issn 1078-0432, 8 p.Article

Inhibition of leukemic cell growth by a novel anti-cancer drug (GUT-70) from Calophyllum brasiliense that acts by induction of apoptosisKIMURA, Shinya; ITO, Chihiro; FURUKAWA, Hiroshi et al.International journal of cancer. 2005, Vol 113, Num 1, pp 158-165, issn 0020-7136, 8 p.Article

NAD(P)H oxidases in rat basilar arterial endothelial cellsAGO, Tetsuro; KITAZONO, Takanari; IIDA, Mitsuo et al.Stroke (1970). 2005, Vol 36, Num 5, pp 1040-1046, issn 0039-2499, 7 p.Article

Zoledronate synergises with imatinib mesylate to inhibit Ph⁺ primary leukaemic cell growthSEGAWA, Hidekazu; KIMURA, Shinya; OTTMANN, Oliver G et al.British journal of haematology. 2005, Vol 130, Num 4, pp 558-560, issn 0007-1048, 3 p.Article